| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 18,750 | 18,780 | 11:44 | |
| 18,740 | 18,790 | 11:44 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 18,730 | 604 | |||
| 18,720 | 289 | |||
| 18,710 | 105 | |||
| 18,700 | 1.291 | |||
| 18,690 | 112 | |||
| 18,670 | 542 | |||
| 18,660 | 1.003 | |||
| 18,650 | 50 | |||
| 18,640 | 50 | |||
| 18,630 | 175 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/gxi.htm [/URL] | ||||
| 67 | 18,580 | |||
| 175 | 18,570 | |||
| 417 | 18,560 | |||
| 50 | 18,550 | |||
| 888 | 18,540 | |||
| 189 | 18,530 | |||
| 653 | 18,520 | |||
| 584 | 18,510 | |||
| 632 | 18,500 | |||
| 151 | 18,490 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.806 | 1,109 | 4.221 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 11:26:58 | 18,580 | 375 |
| 11:26:58 | 18,570 | 5 |
| 11:24:11 | 18,520 | 3 |
| 11:24:11 | 18,520 | 1 |
| 11:23:42 | 18,520 | 3 |
| 11:21:16 | 18,540 | 32 |
| 11:21:08 | 18,550 | 123 |
| 11:20:07 | 18,570 | 1 |
| 11:19:51 | 18,570 | 4 |
| 11:16:41 | 18,590 | 11 |
| 11:16:41 | 18,570 | 277 |
| 11:16:41 | 18,580 | 26 |
| 11:15:34 | 18,580 | 1.216 |
| 11:15:34 | 18,580 | 34 |
| 11:07:45 | 18,620 | 50 |
| 11:07:45 | 18,610 | 66 |
| 11:07:45 | 18,610 | 50 |
| 11:07:45 | 18,600 | 589 |
| 11:03:47 | 18,530 | 3 |
| 10:54:58 | 18,550 | 281 |
| Tagesumsatz Xetra | -0,070 -0,38 % | 57.705 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:30 | SCHOCKMELDUNG: Gerresheimer-Aktie bricht ein - Insider verkaufen massiv! | Hebelschein-Spekulant | |||
| 10:15 | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 265 | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| 10:09 | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 207 | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| 10:09 | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 246 | EQS Group (EN) | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| GERRESHEIMER Aktie jetzt für 0€ handeln | |||||
| 09:14 | GERRESHEIMER AG - Stabilität mit stiller Perspektive | 19 | Maximilian Berger |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 11:15 | Dividendenbekanntmachungen (12.03.2026) | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALAMOS GOLD INC CA0115321089 0,04 USD 0,0346 EUR ALPINE INCOME PROPERTY TRUST INC US02083X1037 0,3 USD 0,2597 EUR ALPINE INCOME... ► Artikel lesen | |
| Mi | EQS-Adhoc: CubeDoc SE: Veränderung im Verwaltungsrat | EQS Group (DE) | EQS-Ad-hoc: CubeDoc SE / Schlagwort(e): Personalentscheidungen / Sonstige Schlüsselposition
CubeDoc SE: Veränderung im Verwaltungsrat
11.03.2026 / 15:48 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| 08:30 | BARCLAYS stuft Fresenius SE auf 'Overweight' | dpa-AFX-Analyser | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Fresenius mit einem Kursziel von 57 Euro auf "Overweight" belassen. Das Nahost-Geschäft bringe weniger als ein... ► Artikel lesen | |
| 08:26 | HEALWELL AI: HEALWELL AI Reaches 47 Peer-Reviewed Publications, Strengthening Its Scientific Moat for AI-Powered Real-World Clinical Evidence Generation | Newsfile | HEALWELL achieves its 47th total peer-reviewed publication validating its DARWEN AI across multiple disease areas and diverse patient populations.HEALWELL presented new scientific validation of... ► Artikel lesen | |
| Mi | Getinge Group: First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat | PR Newswire | STOCKHOLM, March 11, 2026 /PRNewswire/ -- Gesynta Pharma AB today announced that the first patient has been dosed in its Phase 2 clinical proof-of-concept trial (NOVA) of vipoglanstat, a... ► Artikel lesen |